Case study / Allergan (now part of AbbVie)

Allergan / AbbVie: An Object Recognition Table Built for Shared Discovery

DesignExhibitionsExperiential
Explore the impact

01From passive message to shared action

Two screens. One canvas. Every side is an entrance.

A physical question-and-reveal journey made complex messaging approachable, while a joined technical system allowed several delegates to participate around one central experience.

01

Approach

An island layout invites delegates from every side rather than creating a front-facing queue.

02

Question

Clear content turns a pharmaceutical message into an accessible choice.

03

Choose

A physical letter puck gives the participant something tangible to consider and select.

04

Place

The recognition surface identifies the object and responds immediately.

05

Discover

Correct choices progressively assemble the final brand-related word.

NEXT

Reskin

The core framework can carry new content without rebuilding the interaction.

0× 55″

One joined canvas

Two recognition displays synchronised to behave as one continuous surface

0+

Interactions a day

A central experience designed to convert stand traffic into participation

0- 60 sec

Meaningful dwell

Long enough to complete the journey and absorb the message

Every side active

Multi-direction design

No single front, no conventional queue and no staff-led explanation required

Physical digital

Object recognition

Letter pucks gave delegates a tangible way to control responsive content

One accountable team

Joined-up delivery

Creative, software, recognition hardware and exhibition integration resolved together

Reusable core

Designed to evolve

Future messages can be introduced without rebuilding the application

Take the story with you

Download the complete case study

Explore the thinking, delivery and results behind the project, together with the complete image gallery.

Designed case studyDownload PDF

02The project story

Behind the experience

The thinking, delivery and outcome

Turning a message into something people could do.

Allergan needed more than another touchscreen on a pharmaceutical exhibition stand. The experience had to draw delegates in from every direction, make a key brand message easy to understand and give several people a reason to participate without relying on a staff-led demonstration.

Hub9 reframed the brief as a shared island experience. Physical letter pucks, responsive content and two linked object-recognition displays created an intuitive journey that delegates could explore and complete together.

Two screens, one continuous experience.

The defining decision was to network two 55-inch object-recognition screens and make them behave as one generous digital canvas. That created the scale and presence the stand needed without allowing the interaction to feel like two separate devices placed side by side.

The content, orientation and physical actions were designed for use from multiple directions. Rather than forming a conventional queue in front of a display, visitors could gather around the table and take part concurrently.

Choose, place and discover.

Delegates answered a sequence of questions by selecting physical letter pucks and placing them on the recognition surface. The table identified each choice, responded to correct and incorrect answers and progressively assembled a final word connected to the brand message.

Complex software and calibration disappeared behind a simple action. The result felt physical and immediate: choose an object, place it on the table and see the story respond.

Designed as one joined-up system.

Hub9 brought interaction design, content development, software, hardware integration and exhibition delivery together through one team. Screen synchronisation, puck recognition, content logic and the realities of venue lighting were resolved as parts of the same experience rather than separate supplier packages.

This protected reliability at show open and gave the client one accountable delivery partner for the entire system.

Built to evolve beyond one event.

The application and content framework were structured for reskinning and future updates. New messages could be introduced without rebuilding the core recognition experience, protecting the initial investment and making later versions faster to create.

The finished centrepiece generated more than 250 interactions per day, with typical engagement lasting 30 – 60 seconds. More importantly, it transformed passive pharmaceutical messaging into a memorable shared action and created a reusable foundation for future audience experiences.

Start a conversation

What could we make possible for you?

Tell us what you are planning, where the complexity sits and what a successful outcome needs to look like. One of our team will call you back.



    Search